Process for the preparation of CCR-2 antagonists

Details Process for the preparation of CCR-2 antagonists Process for the preparation of CCR-2 antagonists

2008-04-22

2008-04-22

Seman, Margaret D. (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

active

07361765

ABSTRACT:
The present invention provides an efficient synthesis for the preparation of ((1R,3S)-3-isopropyl-3-{[3-(trifluoromethyl)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl]carbonyl}cyclopentyl)[(3S,4S)-3-m ethoxytetrahydro-2H-pyran-4-yl]amine and its succinate salt. The present invention additionally provides an efficient syntheses for the preparation of intermediates (3R)-3-methoxytetrahydro-4H-pyran-4-one; (1S,4S)-4-(2,5-dimethyl-1H-pyrrol-1-yl)-1-isopropylcyclopent-2-ene-1-carboxylic acid; and 3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,6-naphthyridine; and for the preparation of the precursor (3S,4S)-N-((1S,4S)-4-isopropyl-4-{[3-(tri-fluoromethyl)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl]carbonyl}cyclopent-2-en-1-yl)-3-methoxytetrahydro-2H-pyran-4-amine. The invention additionally resides in the superior properties of the succinate salt of ((1R,3S)-3-isopropyl-3-1{[3-(trifluoromethyl)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl]carbonyl}cyclopentyl)[(3S,4S)-3-methoxytetrahydro-2H-pyran-4-yl]amine

REFERENCES:
patent: 03/092586 (2003-11-01), None
patent: WO 03/092586 (2003-11-01), None
Bruekelman, S.P., et al., Jornal of the Chemical Society, pp. 2801-2807, 1984.
Marcoux, J0-F, et al, Organic Letters, vol. 3, No. 2, pp. 209-211, 2001.

Affiliated with

Also associated with

Rating

Process for the preparation of CCR-2 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for the preparation of CCR-2 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the preparation of CCR-2 antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2785036